ART4 and malignant glioma: Through unbiased proteomic analysis we identified a diverse set of ECM-associated proteins that are highly expressed in pediatric high-grade gliomas (HGGs), with several proteoglycans, glycoproteins, and collagens emerging as potential immunotherapeutic targets.